Skip to content
StockMarketAgent
Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

FRA/YPH stock hub

FRA/YPH has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

FRA/YPHis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
22.4B
Frankfurt Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
FRA/YPH
In the news

Latest news · FRA/YPH

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/E14.1
P25 n/aP50 n/aP75 n/a
ROE17.4
P25 n/aP50 n/aP75 n/a
ROIC13.9
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All FRA/YPH market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
225
Groups with data
11
Currency
JPY
Showing 225 of 225 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
Japan
Country code
DE
Employees
13,643
Employees Change
-1,111%
Employees Change Percent
-7.53
Enterprise value
EUR 23.9B
Exchange
Frankfurt Stock Exchange
Financial currency
JPY
First seen
2026-05-10
Industry
Pharmaceutical Preparations
Last refreshed
2026-05-10
Market cap
EUR 22.4B
Price
EUR 12.2
Price currency
EUR
Rev Per Employee
855,281.69x
Sic
2834
Symbol
fra/YPH
Website
https://www.astellas.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

13
MetricValue
Earnings Yield
7.11%
EV Earnings
15.03x
EV/EBIT
11.65x
EV/EBITDA
7.69x
EV/FCF
8.72x
EV/Sales
2.06x
FCF yield
12.26%
P/B ratio
2.24x
P/E ratio
14.06x
P/S ratio
1.92x
PE Ratio10 Y
49.25x
PE Ratio3 Y
122.39x
PE Ratio5 Y
83.42x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

24
MetricValue
EBIT Margin
17.77%
EBITDA Margin
26.86%
FCF margin
23.49%
Gross margin
80.91%
Gross Profit
EUR 9.4B
Gross Profit Growth
10.73%
Gross Profit Growth Q
17.81%
Gross Profit Growth3 Y
12.05%
Gross Profit Growth5 Y
11.52%
Net Income
EUR 1.6B
Net Income Growth
474.49%
Net Income Growth Q
-3.93%
Net Income Growth3 Y
43.47%
Net Income Growth5 Y
19.31%
Pretax Margin
17.6%
Profit Margin
13.63%
Profit Per Employee
EUR 116,557
ROA
6.88
Roa5y
5.24
ROCE
16.18
ROE
17.44
Roe5y
7.43
ROIC
13.91
Roic5y
11.09

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

25
MetricValue
Cagr10y
3.49%
Cagr15y
8.85%
Cagr1y
50.55%
Cagr3y
-0.09%
Cagr5y
2.95%
Div CAGR10
5.94%
Div CAGR3
0.8%
Div CAGR5
5.45%
EPS Growth
474.4
EPS Growth Q
-2.84
EPS Growth3 Y
44.21
EPS Growth5 Y
20.11
FCF Growth
219.01%
FCF Growth Q
34.67%
FCF Growth3 Y
19.92%
FCF Growth5 Y
12.77%
OCF Growth
188%
OCF Growth Q
37.32%
OCF Growth10 Y
5.97%
OCF Growth3 Y
19.56%
OCF Growth5 Y
12.79%
Revenue Growth
11.87x
Revenue Growth Q
20.74x
Revenue Growth3 Y
12.1x
Revenue Growth5 Y
11.35x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

21
MetricValue
Asset Turnover
EUR 0.62
Assets
EUR 19.5B
Cash
EUR 1.5B
Current Assets
EUR 7.7B
Current Liabilities
EUR 6.6B
Debt
EUR 3.1B
Debt EBITDA
EUR 0.98
Debt Equity
EUR 0.31
Debt FCF
EUR 1.13
Equity
EUR 10B
Interest Coverage
27.01
Liabilities
EUR 9.5B
Long Term Assets
EUR 11.8B
Long Term Liabilities
EUR 2.9B
Net Cash
EUR -1.6B
Net Cash By Market Cap
EUR -6.94
Net Debt EBITDA
EUR 0.49
Net Debt Equity
EUR 0.16
Net Debt FCF
EUR 0.57
Tangible Book Value
EUR 2.1B
Tangible Book Value Per Share
EUR 1.19

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.17
Inventory Turnover
1.3
Net Working Capital
EUR 915.6M
Quick ratio
0.86
Working Capital
EUR 1.1B
Working Capital Turnover
EUR 0.07

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
0%
Dividend Growth
-4.63%
Dividend Growth Years
10%
Dividend per share
EUR 0.43
Dividend Years
22
Dividend Yield
3.56%
Ex Div Date
2026-03-30
Last Dividend
EUR 0.21
Payout Frequency
Semi-Annual
Payout Ratio
46.68%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

36
MetricValue
10Y total return
40.86%
1Y total return
50.51%
200-day SMA
11
3Y total return
-0.27%
50-day SMA
13.11
50-day SMA vs 200-day SMA
50over200
5Y total return
15.62%
All Time High
16.7
All Time High Change
-26.95%
All Time High Date
2020-02-11
All Time Low
4.5
All Time Low Change
170.99%
All Time Low Date
2009-03-10
ATR
0.31
Ch YTD
9.61
High
12.2
High52
14.19
High52 Date
2026-04-01
High52ch
-14.02%
Low
12.2
Low52
7.85
Low52 Date
2025-07-10
Low52ch
55.45%
Ma50ch
-6.96%
Price vs 200-day SMA
10.94%
RSI
44.04
RSI Monthly
58.32
RSI Weekly
53.61
Sharpe ratio
1.41x
Sortino ratio
2.27
Total Return
3.56%
Tr YTD
11.35
Tr15y
256.71%
Tr1m
-11.59%
Tr1w
3.39%
Tr3m
-6.15%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
EUR 2.1B
Operating Income Growth
44.21
Operating Income Growth Q
7.59
Operating Income Growth3 Y
17.94
Operating Income Growth5 Y
8.66
Operating margin
17.77

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
1,791,190,258%
Net Borrowing
-1,531,186,293
Shares Insiders
0.02%
Shares Institutions
53.95%
Shares Qo Q
0%
Shares Yo Y
-0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

60
MetricValue
Adjusted FCF
EUR 2.7B
Average Volume
256.75x
Bv Per Share
5.57
CAPEX
EUR -314.9M
Ch10y
4.1
Ch15y
131.1
Ch1m
-11.59
Ch1w
3.39
Ch1y
44.55
Ch3m
-7.61
Ch3y
-12.1
Ch5y
-3.86
Ch6m
30.09
Change
0%
Change From Open
0
Close
12.2
Days Gap
0
Depreciation Amortization
1,053,255,514.5
Earnings Date
2026-04-27
EBIT
EUR 2.1B
EBITDA
EUR 3.1B
EPS
EUR 0.88
F Score
7
FCF
EUR 2.7B
FCF EV Yield
11.47x
Financing CF
-2,207,885,271
Fiscal Year End
March
Founded
1,923
Goodwill
2,387,894,804.5
Graham Number
10.31739
Graham Upside
-15.43
Income Tax
EUR 463.7M
Investing CF
-363,938,151
Is Primary Listing
0
Last Earnings Date
2026-04-27
Last Report Date
2026-03-31
Last Split Date
2014-03-27
Last Split Type
Forward
Lynch Fair Value
EUR 16.76
Lynch Upside
37.38
Ma150
11.6
Ma150ch
5.21%
Ma20
12.85
Ma20ch
-5.06%
Net CF
508,543,594
Open
12.2
P FCF Ratio
8.16
P OCF Ratio
7.32
Payment Date
2026-06-03
Ppne
1,939,998,430.1
Price Date
2026-05-08
Price EBITDA
EUR 7.13
Ptbv Ratio
10.48
Relative Volume
1.02x
Revenue
11,668,608,119x
Tax By Revenue
3.97x
Tax Rate
22.57%
Tr6m
32.15%
Volume
0
Z Score
2.48
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

FRA/YPH dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+3.6%
$0.43 annual per share
Payout ratio
+46.7%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+5.5%
10 consecutive years of growth
Total shareholder yield
+3.6%
Next ex-dividend date: 2026-03-30
Performance

FRA/YPH stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+50.5%
S&P 500 1Y: n/a
3Y total return
-0.3%
S&P 500 3Y: n/a
5Y total return
+15.6%
S&P 500 5Y: n/a
10Y total return
+40.9%
S&P 500 10Y: n/a
Ownership

Who owns FRA/YPH?

Insider, institutional, and short-interest positioning.

Institutional ownership
+54.0%
Share of float held by funds and institutions
Insider ownership
+0.0%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-0.0%
Negative means the company is buying back shares.
Technical

FRA/YPH momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
44.0
Neutral momentum band
Price vs 200-day MA
+10.9%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
1.41
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About FRA/YPH

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/YPH stock rating?

fra/YPH is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/YPH analysis?

The full report lives at /stocks/fra/YPH/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/YPH?

The latest report frames fra/YPH around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/YPH page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

fra/YPH stock profile: metrics, valuation and analysis | Stock Market Agent AI